MAP2K7 and melanoma: Based on our proposed mechanism whereby MLKs can activate the MEK/ERK pathway in a manner independent of the RAF kinases, we sought to determine whether MLKs may mediate reactivation of this pathway in the presence of RAF inhibitors in V600E-positive melanoma cells.